Vidipha Central Pharmaceutical JSC

HOSE-VDP
Ho Chi Minh Stock Exchange
Pharmaceutical Preparations
Global Rank
#33552
Country Rank
#314
Market Cap
30.52 M
Price
1.47
Change (%)
3.51%
Volume
720

Vidipha Central Pharmaceutical JSC's latest marketcap:

30.52 M

As of 08/03/2025, Vidipha Central Pharmaceutical JSC's market capitalization has reached $30.52 M. According to our data, Vidipha Central Pharmaceutical JSC is the 33552th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 30.52 M
Revenue (ttm) 0
Net Income (ttm) 0
Shares Out 22.08 M
EPS (ttm) 0
Forward PE 0.00
Ex-Dividend Date 03/19/2025
Earnings Date 08/15/2025
Market Cap Chart
Data Updated: 08/03/2025

Vidipha Central Pharmaceutical JSC's yearly market capitalization.

Vidipha Central Pharmaceutical JSC has seen its market value grow from ₫478.6 B to ₫799.42 B since 2017, representing a total increase of 67.03% and an annual compound growth rate (CAGR) of 6.99%.
Date Market Cap(₫) Market Cap(USD) Change (%) Global Rank
08/03/2025 ₫799.42 B $30.52 M -2.16% 33552
12/31/2024 ₫817.09 B $32.68 M 13.85% 30916
12/27/2023 ₫717.72 B $28.71 M 13.71% 31457
12/30/2022 ₫631.2 B $25.25 M 1.57% 31326
12/31/2021 ₫621.43 B $24.86 M 23.96% 31633
12/31/2020 ₫501.31 B $20.05 M 21.49% 29479
12/31/2019 ₫412.64 B $16.51 M 0.1% 27148
12/28/2018 ₫412.23 B $16.49 M -13.87% 26134
12/29/2017 ₫478.6 B $19.14 M 25674

Company Profile

Vidipha Central Pharmaceutical Joint Stock Company Overview

Vidipha Central Pharmaceutical Joint Stock Company specializes in the production and distribution of pharmaceutical products under the Vidipha brand. Headquartered in Ho Chi Minh City, Vietnam, the company serves both domestic and international markets.

Product Portfolio

The company offers a diverse range of medicines, including:

  • Antibiotics & Anti-inflammatory drugs
  • Vitamins & Mineral salts
  • Pain relievers & Antipyretics
  • Anti-allergy medications
  • Treatments for worm, fluke, respiratory, gastrointestinal, and skin diseases

Product Forms

Vidipha Central Pharmaceutical provides medicines in various forms, such as:

  • Compress and capsule pills
  • Powdered granules and injectable solutions
  • Syrups and drinking tubes
  • Eye and nose drops
  • Topical creams and ointments

Distribution Network

The company supplies its products through:

  • Pharmaceutical companies
  • Hospitals and clinics
  • Retail pharmacies

Additionally, Vidipha Central Pharmaceutical exports to CIS countries, expanding its global reach.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.